±¾¹«Ë¾¼°¶Ê»áÈ«Ìå³ÉÔ±°ü¹ÜÐÅÏ¢Åû¶ÄÚÈݵÄÕæÊµ¡¢×¼È·ºÍÍêÕû£¬Ã»ÓÐÐéα¼Í¼¡¢Îóµ¼ÐÔ³ÂÊö»òÖØ´óÒÅ©¡£Õã½ÈËÉú¾ÍÊDz©¡¤(ÖйúÇø)¼¯ÍŹÙÍøÖÆÒ©¹É·ÝÓÐÏÞ¹«Ë¾£¨ÒÔϼò³Æ¡°¹«Ë¾¡±£©È«×Ê×Ó¹«Ë¾Ì¨ÖÝÈËÉú¾ÍÊDz©¡¤(ÖйúÇø)¼¯ÍŹÙÍøÒ©ÒµÓÐÏÞ¹«Ë¾£¨ÒÔϼò³Æ¡°Ì¨ÖÝÈËÉú¾ÍÊDz©¡¤(ÖйúÇø)¼¯ÍŹÙÍø¡±£©ÓÚ2024Äê11ÔÂ11ÈÕ-15ÈÕ½ÓÊÜÁËÀ´×ÔÃÀ¹úʳÎïÒ©Æ·¼àÊÓ¹ÜÀí¾Ö£¨ÒÔϼò³Æ¡°FDA¡±£©µÄ cGMP£¨ÏÖÐÐÒ©Æ·Éú²úÖÊÁ¿¹ÜÀí¹æ·¶£©ÏÖ³¡¼ì²é¡£¿ËÈǪ̃ÖÝÈËÉú¾ÍÊDz©¡¤(ÖйúÇø)¼¯ÍŹÙÍøÊÕµ½FDA³ö¾ßµÄÏÖ³¡¼ì²é±¨¸æ£¨EIR£¬Establishment Inspection Report£©£¬Æ¾Ö¤ÃÀ¹ú21CFR ¹æÔò£¨ÃÀ¹úÁª°î¹æÔòµÚ21Õ£©µÄ»®¶¨£¬FDAÈ·Èϱ¾´Î¼ì²éÒÑ¿¢Ê£¬Ì¨ÖÝÈËÉú¾ÍÊDz©¡¤(ÖйúÇø)¼¯ÍŹÙÍøÍ¨¹ý±¾´ÎÏÖ³¡¼ì²é¡£ÏÖ½«Ïà¹ØÐÅϢͨ¸æÈçÏ£ºÒ»¡¢FDAÏÖ³¡¼ì²éµÄÏà¹ØÐÅÏ¢¹«Ë¾Ãû³Æ£ºÌ¨ÖÝÈËÉú¾ÍÊDz©¡¤(ÖйúÇø)¼¯ÍŹÙÍøÒ©ÒµÓÐÏÞ¹«Ë¾
Éú²úµØÖ·£ºÕã½Ê¡Ì¨ÖÝÊÐÁÙº£ÊÐÕã½Í·ÃŸ۾¼Ã¿ª·¢Çø¶«º£µÚËÄ´óµÀ3ºÅ
FDA FEI£º3012045665
¼ì²éʱ¼ä£º2024 Äê11ÔÂ11ÈÕ-15ÈÕ
¼ì²éÀàÐÍ£ºÒ»Ñùƽ³£î¿Ïµ¼ì²é
¼ì²é¹æÄ££ºÂÞ¿âäåï§¡¢Î¬¿âäåï§¡¢ÆÃÄáËÉ¡¢Ç⻯¿ÉµÄËɵÈÖÊÁÏÒ©
¼ì²éЧ¹û£ºNAI£¨No Action Indicated£©¶þ¡¢¶Ô¹«Ë¾µÄÓ°Ï켰Σº¦ÌáÐѱ¾´Î¼ì²éµÄͨ¹ý£¬Åúע̨ÖÝÈËÉú¾ÍÊDz©¡¤(ÖйúÇø)¼¯ÍŹÙÍøÖÊÁ¿ÏµÍ³ÇкÏÃÀ¹úFDAÒªÇó£¬Îª¹«Ë¾Ò»Á¬ÍØÕ¹¹ú¼ÊÊг¡ÌṩÁ˼áʵµÄ°ü¹Ü£¬Ìá¸ßÁ˹«Ë¾ÖÊÁÏÒ©²úÆ·µÄ¹ú¼ÊÊг¡¾ºÕùÁ¦£¬¶ÔÌáÉý¹«Ë¾×ۺϾºÕùÁ¦¼°Î´À´Éú³¤ÓÐ×ÅÆð¾¢µÄÍÆÐж¯Óá£ÓÉÓÚÒ½Ò©²úÆ·µÄÐÐÒµÌØµã£¬¹ú¼ÊÖÊÁÏÒ©ÓªÒµÒ×ÊÜÍâÑóÊг¡ÇéÐÎת±ä¡¢ÐÐÒµÕþ²ß¡¢¹©Çó¹ØÏµµÈÒòËØÓ°Ï죬¾ßÓÐÒ»¶¨µÄ²»È·¶¨ÐÔ¡£¾´Çë¿í´óͶ×ÊÕßÀíÐÔͶ×Ê£¬×¢ÖØÍ¶×ÊΣº¦¡£
ÌØ´Ëͨ¸æ¡£
ÈËÉú¾ÍÊDz©¡¤(ÖйúÇø)¼¯ÍŹÙÍø¶Ê»á